Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Brain Neoplasms | 64 | 2024 | 9031 | 5.180 |
Why?
|
Glioma | 35 | 2024 | 3455 | 4.360 |
Why?
|
Glioblastoma | 26 | 2024 | 3482 | 2.920 |
Why?
|
Meningeal Neoplasms | 12 | 2024 | 1248 | 2.080 |
Why?
|
Meningioma | 10 | 2024 | 1218 | 2.030 |
Why?
|
Magnetic Resonance Imaging | 58 | 2024 | 36426 | 1.660 |
Why?
|
Angiogenesis Inhibitors | 9 | 2021 | 2047 | 1.500 |
Why?
|
Isocitrate Dehydrogenase | 12 | 2024 | 938 | 1.350 |
Why?
|
Neoplasm Recurrence, Local | 15 | 2023 | 9280 | 0.960 |
Why?
|
Tumor Burden | 9 | 2023 | 1893 | 0.920 |
Why?
|
Artificial Intelligence | 9 | 2024 | 2578 | 0.750 |
Why?
|
Glutarates | 2 | 2020 | 243 | 0.700 |
Why?
|
Central Nervous System Neoplasms | 3 | 2021 | 916 | 0.620 |
Why?
|
Image Interpretation, Computer-Assisted | 8 | 2024 | 3357 | 0.560 |
Why?
|
Tomography, X-Ray Computed | 16 | 2024 | 20570 | 0.550 |
Why?
|
Cranial Irradiation | 1 | 2019 | 390 | 0.540 |
Why?
|
Trauma Centers | 1 | 2020 | 937 | 0.480 |
Why?
|
Tyrosine | 1 | 2018 | 1440 | 0.460 |
Why?
|
Cervical Vertebrae | 1 | 2020 | 980 | 0.450 |
Why?
|
Wounds, Nonpenetrating | 1 | 2020 | 807 | 0.450 |
Why?
|
World Health Organization | 1 | 2019 | 1322 | 0.440 |
Why?
|
Humans | 122 | 2024 | 761504 | 0.430 |
Why?
|
Mutation | 16 | 2024 | 30052 | 0.420 |
Why?
|
Spinal Cord Injuries | 1 | 2020 | 925 | 0.410 |
Why?
|
Iohexol | 1 | 2013 | 204 | 0.410 |
Why?
|
Radiosurgery | 3 | 2020 | 1342 | 0.410 |
Why?
|
Magnetic Resonance Spectroscopy | 2 | 2020 | 3769 | 0.380 |
Why?
|
Temporal Lobe | 1 | 2019 | 1695 | 0.380 |
Why?
|
Retrospective Studies | 39 | 2023 | 80636 | 0.380 |
Why?
|
Cerebellar Neoplasms | 3 | 2022 | 586 | 0.370 |
Why?
|
Public Health | 1 | 2024 | 2669 | 0.370 |
Why?
|
Radiotherapy Planning, Computer-Assisted | 1 | 2019 | 1661 | 0.350 |
Why?
|
Middle Aged | 50 | 2024 | 220895 | 0.320 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 3 | 2021 | 5315 | 0.300 |
Why?
|
Adult | 47 | 2024 | 221177 | 0.290 |
Why?
|
Cerebral Angiography | 1 | 2013 | 1281 | 0.290 |
Why?
|
Chromosomes, Human, Pair 19 | 2 | 2019 | 350 | 0.290 |
Why?
|
Aorta, Thoracic | 1 | 2013 | 1096 | 0.280 |
Why?
|
Radiotherapy, Adjuvant | 4 | 2019 | 1784 | 0.270 |
Why?
|
Diagnostic Imaging | 4 | 2022 | 3530 | 0.270 |
Why?
|
Combined Modality Therapy | 4 | 2020 | 8529 | 0.270 |
Why?
|
Duodenal Diseases | 1 | 2007 | 100 | 0.270 |
Why?
|
Cerebrovascular Disorders | 1 | 2013 | 1474 | 0.270 |
Why?
|
Prognosis | 15 | 2024 | 29625 | 0.270 |
Why?
|
Chromosomes, Human, Pair 1 | 2 | 2019 | 638 | 0.270 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 1 | 2013 | 1222 | 0.260 |
Why?
|
Young Adult | 24 | 2020 | 59243 | 0.260 |
Why?
|
Medulloblastoma | 2 | 2022 | 678 | 0.260 |
Why?
|
Central Nervous System Diseases | 2 | 2020 | 520 | 0.260 |
Why?
|
Diverticulum | 1 | 2007 | 137 | 0.250 |
Why?
|
Aged | 36 | 2024 | 169289 | 0.250 |
Why?
|
Aged, 80 and over | 21 | 2020 | 58976 | 0.250 |
Why?
|
Male | 50 | 2024 | 360804 | 0.240 |
Why?
|
Observer Variation | 4 | 2021 | 2606 | 0.240 |
Why?
|
Intestinal Perforation | 1 | 2007 | 249 | 0.240 |
Why?
|
Female | 52 | 2024 | 392644 | 0.240 |
Why?
|
Neoplasm, Residual | 2 | 2020 | 1008 | 0.230 |
Why?
|
DNA Repair Enzymes | 2 | 2018 | 346 | 0.230 |
Why?
|
Brain | 8 | 2022 | 27112 | 0.230 |
Why?
|
Positron-Emission Tomography | 2 | 2024 | 6485 | 0.220 |
Why?
|
Receptors, Somatostatin | 1 | 2024 | 136 | 0.220 |
Why?
|
Diffusion Magnetic Resonance Imaging | 5 | 2023 | 2790 | 0.220 |
Why?
|
Ovariectomy | 2 | 2003 | 614 | 0.210 |
Why?
|
Clinical Trials as Topic | 1 | 2019 | 8002 | 0.210 |
Why?
|
Disease Progression | 8 | 2019 | 13506 | 0.210 |
Why?
|
Amnesia, Transient Global | 1 | 2022 | 20 | 0.210 |
Why?
|
Nandrolone | 1 | 2002 | 17 | 0.200 |
Why?
|
Neurosurgical Procedures | 3 | 2024 | 2072 | 0.200 |
Why?
|
Follow-Up Studies | 12 | 2019 | 39106 | 0.200 |
Why?
|
Practice Guidelines as Topic | 2 | 2019 | 7390 | 0.200 |
Why?
|
Melanoma | 1 | 2020 | 5709 | 0.200 |
Why?
|
Lung Neoplasms | 3 | 2021 | 13380 | 0.200 |
Why?
|
Lymphoma | 2 | 2022 | 1901 | 0.200 |
Why?
|
Creutzfeldt-Jakob Syndrome | 1 | 2022 | 93 | 0.200 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 2 | 2022 | 1405 | 0.180 |
Why?
|
Carcinoma, Renal Cell | 3 | 2020 | 3164 | 0.180 |
Why?
|
Emergency Service, Hospital | 1 | 2020 | 7879 | 0.180 |
Why?
|
Spinal Cord Neoplasms | 1 | 2023 | 263 | 0.180 |
Why?
|
Optic Nerve | 1 | 2024 | 572 | 0.180 |
Why?
|
Chemotherapy, Adjuvant | 2 | 2019 | 3514 | 0.170 |
Why?
|
Disease-Free Survival | 5 | 2020 | 6814 | 0.170 |
Why?
|
Discitis | 1 | 2020 | 45 | 0.170 |
Why?
|
Ovarian Cysts | 1 | 2020 | 108 | 0.170 |
Why?
|
Infratentorial Neoplasms | 1 | 2020 | 98 | 0.170 |
Why?
|
Intraoperative Period | 1 | 2020 | 510 | 0.160 |
Why?
|
Anabolic Agents | 1 | 2002 | 256 | 0.160 |
Why?
|
Kidney Neoplasms | 3 | 2020 | 4249 | 0.160 |
Why?
|
Algorithms | 8 | 2024 | 14031 | 0.160 |
Why?
|
Dictionaries as Topic | 1 | 2018 | 11 | 0.160 |
Why?
|
Encephalitis | 1 | 2022 | 438 | 0.160 |
Why?
|
Cerebral Veins | 1 | 2019 | 157 | 0.150 |
Why?
|
Whole Body Imaging | 1 | 2020 | 283 | 0.150 |
Why?
|
Medical Oncology | 3 | 2024 | 2321 | 0.150 |
Why?
|
Antineoplastic Agents | 4 | 2020 | 13639 | 0.150 |
Why?
|
Hemangioblastoma | 1 | 2018 | 62 | 0.150 |
Why?
|
Reproducibility of Results | 10 | 2024 | 20098 | 0.150 |
Why?
|
Stereotaxic Techniques | 1 | 2020 | 555 | 0.150 |
Why?
|
Postoperative Period | 2 | 2020 | 1813 | 0.150 |
Why?
|
Survival Rate | 8 | 2019 | 12725 | 0.140 |
Why?
|
Consensus | 6 | 2023 | 3123 | 0.140 |
Why?
|
Contrast Media | 6 | 2020 | 5311 | 0.140 |
Why?
|
Facial Nerve | 1 | 2019 | 277 | 0.140 |
Why?
|
Oropharyngeal Neoplasms | 1 | 2023 | 491 | 0.140 |
Why?
|
Image Processing, Computer-Assisted | 5 | 2023 | 9000 | 0.140 |
Why?
|
Glycine | 1 | 2020 | 663 | 0.140 |
Why?
|
Unnecessary Procedures | 1 | 2020 | 415 | 0.140 |
Why?
|
Language | 2 | 2019 | 1540 | 0.140 |
Why?
|
Caenorhabditis elegans Proteins | 1 | 2003 | 874 | 0.140 |
Why?
|
Head and Neck Neoplasms | 2 | 2023 | 2895 | 0.130 |
Why?
|
Academic Medical Centers | 2 | 2018 | 2759 | 0.130 |
Why?
|
Necrosis | 1 | 2020 | 1611 | 0.130 |
Why?
|
Perfusion | 1 | 2021 | 1373 | 0.130 |
Why?
|
Tibia | 1 | 2002 | 1070 | 0.130 |
Why?
|
Spinal Stenosis | 1 | 2019 | 261 | 0.130 |
Why?
|
Survival Analysis | 4 | 2018 | 10090 | 0.130 |
Why?
|
STAT6 Transcription Factor | 1 | 2016 | 194 | 0.130 |
Why?
|
Immunotherapy | 3 | 2023 | 4652 | 0.130 |
Why?
|
Nervous System Neoplasms | 1 | 2015 | 91 | 0.120 |
Why?
|
Postoperative Care | 2 | 2019 | 1468 | 0.120 |
Why?
|
Fluorodeoxyglucose F18 | 2 | 2022 | 2010 | 0.120 |
Why?
|
Chordoma | 1 | 2018 | 347 | 0.120 |
Why?
|
Spine | 2 | 2020 | 1118 | 0.120 |
Why?
|
Treatment Outcome | 9 | 2024 | 64680 | 0.120 |
Why?
|
Skull Base Neoplasms | 1 | 2018 | 270 | 0.120 |
Why?
|
Dexamethasone | 1 | 2022 | 1948 | 0.120 |
Why?
|
Lumbar Vertebrae | 2 | 2021 | 1879 | 0.120 |
Why?
|
Osteoporosis | 2 | 2003 | 1606 | 0.120 |
Why?
|
Gallbladder Diseases | 1 | 2015 | 141 | 0.110 |
Why?
|
ROC Curve | 2 | 2020 | 3579 | 0.110 |
Why?
|
Proteomics | 3 | 2005 | 3849 | 0.110 |
Why?
|
Sarcoidosis | 1 | 2019 | 521 | 0.110 |
Why?
|
Predictive Value of Tests | 6 | 2021 | 15266 | 0.110 |
Why?
|
Retreatment | 1 | 2015 | 598 | 0.110 |
Why?
|
Prospective Studies | 7 | 2023 | 54425 | 0.110 |
Why?
|
Patient Admission | 1 | 2021 | 1367 | 0.110 |
Why?
|
Semantics | 1 | 2017 | 601 | 0.110 |
Why?
|
Cohort Studies | 7 | 2022 | 41487 | 0.110 |
Why?
|
Chromosome Deletion | 1 | 2018 | 1386 | 0.110 |
Why?
|
Cholecystectomy, Laparoscopic | 1 | 2015 | 232 | 0.110 |
Why?
|
Neoplasms | 2 | 2019 | 22170 | 0.110 |
Why?
|
Synchrotrons | 2 | 2003 | 39 | 0.110 |
Why?
|
Proportional Hazards Models | 5 | 2021 | 12463 | 0.110 |
Why?
|
Radiopharmaceuticals | 3 | 2024 | 2651 | 0.110 |
Why?
|
Spectrophotometry, Infrared | 2 | 2003 | 117 | 0.110 |
Why?
|
Gene Fusion | 1 | 2016 | 356 | 0.110 |
Why?
|
Clinical Trials, Phase II as Topic | 1 | 2015 | 629 | 0.110 |
Why?
|
Facial Injuries | 1 | 2014 | 190 | 0.110 |
Why?
|
DNA Modification Methylases | 1 | 2013 | 210 | 0.100 |
Why?
|
Clinical Protocols | 1 | 2018 | 1440 | 0.100 |
Why?
|
Bone Density | 2 | 2003 | 3551 | 0.100 |
Why?
|
Radiotherapy Dosage | 1 | 2019 | 2898 | 0.100 |
Why?
|
Pattern Recognition, Automated | 2 | 2023 | 997 | 0.100 |
Why?
|
Brain Diseases | 1 | 2021 | 1545 | 0.100 |
Why?
|
Area Under Curve | 1 | 2016 | 1638 | 0.100 |
Why?
|
Facial Transplantation | 1 | 2014 | 221 | 0.100 |
Why?
|
Salvage Therapy | 2 | 2018 | 1264 | 0.100 |
Why?
|
Brain Mapping | 3 | 2019 | 6630 | 0.090 |
Why?
|
Drug Resistance, Neoplasm | 2 | 2018 | 5305 | 0.090 |
Why?
|
Radiation Injuries | 1 | 2018 | 1189 | 0.090 |
Why?
|
Radiography, Interventional | 1 | 2018 | 1121 | 0.090 |
Why?
|
Pyridines | 2 | 2020 | 2875 | 0.090 |
Why?
|
Sensitivity and Specificity | 5 | 2020 | 14666 | 0.090 |
Why?
|
Papillomavirus Infections | 1 | 2023 | 1613 | 0.090 |
Why?
|
Macaca fascicularis | 2 | 2003 | 903 | 0.090 |
Why?
|
Parietal Lobe | 1 | 2016 | 852 | 0.090 |
Why?
|
Adolescent | 10 | 2020 | 88319 | 0.090 |
Why?
|
Image Enhancement | 2 | 2018 | 2885 | 0.080 |
Why?
|
Subtraction Technique | 1 | 2012 | 512 | 0.080 |
Why?
|
Child | 10 | 2024 | 80153 | 0.080 |
Why?
|
Neoplasm Staging | 5 | 2023 | 11121 | 0.080 |
Why?
|
Internet | 1 | 2020 | 3092 | 0.080 |
Why?
|
Robotics | 1 | 2015 | 819 | 0.080 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 3 | 2018 | 11742 | 0.070 |
Why?
|
Phenotype | 3 | 2020 | 16591 | 0.070 |
Why?
|
Molecular Targeted Therapy | 1 | 2018 | 2811 | 0.070 |
Why?
|
Carcinoma, Squamous Cell | 2 | 2020 | 4026 | 0.070 |
Why?
|
Patient Selection | 1 | 2018 | 4244 | 0.070 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2017 | 3492 | 0.070 |
Why?
|
Neoplasm Proteins | 1 | 2018 | 3617 | 0.070 |
Why?
|
Lomustine | 2 | 2017 | 60 | 0.070 |
Why?
|
Structural Homology, Protein | 1 | 2005 | 87 | 0.060 |
Why?
|
Incidence | 2 | 2021 | 21353 | 0.060 |
Why?
|
United States | 3 | 2024 | 72334 | 0.060 |
Why?
|
Metalloproteins | 1 | 2005 | 101 | 0.060 |
Why?
|
Edema | 2 | 2023 | 766 | 0.060 |
Why?
|
Imaging, Three-Dimensional | 1 | 2018 | 4063 | 0.060 |
Why?
|
Genomics | 4 | 2024 | 5821 | 0.060 |
Why?
|
Repressor Proteins | 1 | 2016 | 2986 | 0.060 |
Why?
|
Diagnosis, Differential | 4 | 2020 | 12974 | 0.060 |
Why?
|
Carbonates | 1 | 2003 | 21 | 0.060 |
Why?
|
Kaplan-Meier Estimate | 3 | 2019 | 6484 | 0.060 |
Why?
|
Preoperative Care | 1 | 2013 | 2242 | 0.060 |
Why?
|
Ovarian Neoplasms | 1 | 2020 | 4876 | 0.060 |
Why?
|
Spectroscopy, Fourier Transform Infrared | 1 | 2003 | 161 | 0.050 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2016 | 3639 | 0.050 |
Why?
|
Tumor Suppressor Proteins | 1 | 2013 | 2803 | 0.050 |
Why?
|
Quality Improvement | 1 | 2018 | 3801 | 0.050 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2020 | 10209 | 0.050 |
Why?
|
Isotope Labeling | 1 | 2024 | 392 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3084 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3204 | 0.050 |
Why?
|
Recombinant Fusion Proteins | 2 | 2017 | 3734 | 0.050 |
Why?
|
Enzyme Inhibitors | 2 | 2024 | 3712 | 0.050 |
Why?
|
Genotype | 1 | 2016 | 12990 | 0.050 |
Why?
|
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2003 | 506 | 0.050 |
Why?
|
Solubility | 1 | 2003 | 1091 | 0.050 |
Why?
|
Diffusion | 1 | 2023 | 814 | 0.050 |
Why?
|
Case-Control Studies | 1 | 2019 | 22176 | 0.050 |
Why?
|
Infarction | 1 | 2022 | 248 | 0.050 |
Why?
|
Losartan | 1 | 2023 | 265 | 0.050 |
Why?
|
Nuclear Medicine | 1 | 2024 | 237 | 0.050 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 1 | 2003 | 1741 | 0.050 |
Why?
|
Propensity Score | 2 | 2019 | 1913 | 0.050 |
Why?
|
Animals | 8 | 2023 | 168459 | 0.050 |
Why?
|
Nerve Net | 1 | 2013 | 2290 | 0.040 |
Why?
|
Osteoporosis, Postmenopausal | 1 | 2003 | 396 | 0.040 |
Why?
|
Ki-67 Antigen | 1 | 2022 | 629 | 0.040 |
Why?
|
Child, Preschool | 5 | 2020 | 42230 | 0.040 |
Why?
|
Bone Remodeling | 1 | 2003 | 581 | 0.040 |
Why?
|
Philadelphia | 1 | 2020 | 266 | 0.040 |
Why?
|
Rhode Island | 1 | 2020 | 351 | 0.040 |
Why?
|
DNA Methylation | 1 | 2013 | 4398 | 0.040 |
Why?
|
DNA Helicases | 1 | 2024 | 851 | 0.040 |
Why?
|
Dilatation, Pathologic | 1 | 2019 | 527 | 0.040 |
Why?
|
Software | 1 | 2012 | 4434 | 0.040 |
Why?
|
Electric Power Supplies | 1 | 2018 | 96 | 0.040 |
Why?
|
Biological Specimen Banks | 1 | 2023 | 783 | 0.040 |
Why?
|
Constriction, Pathologic | 1 | 2021 | 1096 | 0.040 |
Why?
|
Cranial Fossa, Posterior | 1 | 2018 | 135 | 0.040 |
Why?
|
Microsatellite Repeats | 1 | 2020 | 784 | 0.040 |
Why?
|
Rare Diseases | 1 | 2022 | 622 | 0.040 |
Why?
|
Ligands | 1 | 2024 | 3272 | 0.040 |
Why?
|
Benchmarking | 1 | 2024 | 1045 | 0.040 |
Why?
|
Automation | 1 | 2019 | 586 | 0.040 |
Why?
|
Neuroendoscopy | 1 | 2018 | 99 | 0.030 |
Why?
|
Negotiating | 1 | 2018 | 150 | 0.030 |
Why?
|
DNA Mismatch Repair | 1 | 2020 | 428 | 0.030 |
Why?
|
Caenorhabditis elegans | 2 | 2003 | 1456 | 0.030 |
Why?
|
Clinical Trials, Phase III as Topic | 1 | 2020 | 857 | 0.030 |
Why?
|
Microscopy, Fluorescence | 1 | 2003 | 2645 | 0.030 |
Why?
|
Antineoplastic Agents, Alkylating | 1 | 2020 | 617 | 0.030 |
Why?
|
Mutagenesis | 1 | 2020 | 1232 | 0.030 |
Why?
|
Surgical Instruments | 1 | 2018 | 383 | 0.030 |
Why?
|
Bone and Bones | 2 | 2003 | 2568 | 0.030 |
Why?
|
Fluorescent Dyes | 1 | 2003 | 1903 | 0.030 |
Why?
|
Proteome | 2 | 2003 | 1862 | 0.030 |
Why?
|
Preoperative Period | 1 | 2017 | 551 | 0.030 |
Why?
|
Multivariate Analysis | 2 | 2019 | 12059 | 0.030 |
Why?
|
Gadolinium | 1 | 2020 | 960 | 0.030 |
Why?
|
Collagen | 1 | 2003 | 2638 | 0.030 |
Why?
|
Estrogens | 1 | 2002 | 1522 | 0.030 |
Why?
|
Meglumine | 1 | 2015 | 144 | 0.030 |
Why?
|
Genome | 1 | 2003 | 1740 | 0.030 |
Why?
|
National Institutes of Health (U.S.) | 1 | 2018 | 793 | 0.030 |
Why?
|
Central Nervous System | 1 | 2022 | 1336 | 0.030 |
Why?
|
Radiology Information Systems | 1 | 2019 | 529 | 0.030 |
Why?
|
Comparative Genomic Hybridization | 1 | 2016 | 473 | 0.030 |
Why?
|
Carmustine | 1 | 2014 | 138 | 0.030 |
Why?
|
Anilides | 1 | 2017 | 411 | 0.030 |
Why?
|
Information Dissemination | 1 | 2022 | 1126 | 0.030 |
Why?
|
China | 1 | 2020 | 2369 | 0.030 |
Why?
|
Receptors, Vascular Endothelial Growth Factor | 1 | 2017 | 664 | 0.030 |
Why?
|
Craniotomy | 1 | 2018 | 741 | 0.030 |
Why?
|
Gene Expression | 2 | 2003 | 7581 | 0.030 |
Why?
|
Radiography, Thoracic | 1 | 2020 | 1302 | 0.030 |
Why?
|
Adenocarcinoma | 2 | 2021 | 6346 | 0.030 |
Why?
|
Gene Frequency | 1 | 2020 | 3606 | 0.030 |
Why?
|
Bayes Theorem | 1 | 2020 | 2330 | 0.030 |
Why?
|
Cell Cycle Proteins | 1 | 2024 | 3448 | 0.030 |
Why?
|
Histones | 1 | 2023 | 2580 | 0.030 |
Why?
|
Software Validation | 1 | 2012 | 59 | 0.030 |
Why?
|
Chi-Square Distribution | 1 | 2018 | 3416 | 0.020 |
Why?
|
Functional Laterality | 1 | 2019 | 2257 | 0.020 |
Why?
|
Organometallic Compounds | 1 | 2015 | 647 | 0.020 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2020 | 3602 | 0.020 |
Why?
|
Lymph Nodes | 1 | 2023 | 3466 | 0.020 |
Why?
|
Peptides | 1 | 2003 | 4358 | 0.020 |
Why?
|
Neurosurgery | 1 | 2018 | 679 | 0.020 |
Why?
|
Escherichia coli | 1 | 2003 | 4217 | 0.020 |
Why?
|
Seizures | 1 | 2024 | 2957 | 0.020 |
Why?
|
Quinazolines | 1 | 2017 | 1371 | 0.020 |
Why?
|
Tumor Cells, Cultured | 1 | 2018 | 6132 | 0.020 |
Why?
|
United States Food and Drug Administration | 1 | 2018 | 1664 | 0.020 |
Why?
|
Tumor Microenvironment | 1 | 2023 | 3877 | 0.020 |
Why?
|
Lymphatic Metastasis | 1 | 2017 | 2915 | 0.020 |
Why?
|
Nuclear Proteins | 1 | 2024 | 5796 | 0.020 |
Why?
|
Cross-Over Studies | 1 | 2015 | 2078 | 0.020 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2023 | 4580 | 0.020 |
Why?
|
Sequence Analysis, DNA | 1 | 2020 | 4740 | 0.020 |
Why?
|
Pneumonia | 1 | 2020 | 2143 | 0.020 |
Why?
|
DNA, Neoplasm | 1 | 2013 | 1745 | 0.020 |
Why?
|
Infant | 2 | 2020 | 36192 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2020 | 10766 | 0.020 |
Why?
|
Rest | 1 | 2013 | 918 | 0.020 |
Why?
|
Age Factors | 1 | 2024 | 18395 | 0.020 |
Why?
|
Neoplasm Metastasis | 1 | 2018 | 4915 | 0.020 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2013 | 2510 | 0.020 |
Why?
|
Proteins | 1 | 2002 | 6032 | 0.020 |
Why?
|
Genome, Human | 1 | 2020 | 4425 | 0.020 |
Why?
|
Biopsy | 1 | 2018 | 6766 | 0.020 |
Why?
|
Massachusetts | 1 | 2018 | 8830 | 0.020 |
Why?
|
Antibodies, Monoclonal | 1 | 2022 | 9177 | 0.020 |
Why?
|
Spectrometry, X-Ray Emission | 1 | 2005 | 143 | 0.020 |
Why?
|
Decision Making | 1 | 2018 | 3929 | 0.010 |
Why?
|
Mice | 2 | 2023 | 81525 | 0.010 |
Why?
|
Sequence Analysis, Protein | 1 | 2005 | 261 | 0.010 |
Why?
|
Transcription Factors | 1 | 2024 | 12128 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2003 | 18252 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 2013 | 6075 | 0.010 |
Why?
|
Models, Molecular | 2 | 2005 | 5439 | 0.010 |
Why?
|
DNA, Helminth | 1 | 2003 | 35 | 0.010 |
Why?
|
Databases, Protein | 1 | 2005 | 387 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2019 | 14605 | 0.010 |
Why?
|
Expressed Sequence Tags | 1 | 2003 | 250 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2024 | 26125 | 0.010 |
Why?
|
Genes, Helminth | 1 | 2003 | 147 | 0.010 |
Why?
|
Purine Nucleosides | 1 | 2002 | 30 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2020 | 11528 | 0.010 |
Why?
|
Helminth Proteins | 1 | 2003 | 173 | 0.010 |
Why?
|
Databases, Factual | 1 | 2018 | 7967 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2016 | 11076 | 0.010 |
Why?
|
Promoter Regions, Genetic | 1 | 2013 | 5789 | 0.010 |
Why?
|
Gene Order | 1 | 2002 | 169 | 0.010 |
Why?
|
Feasibility Studies | 1 | 2013 | 5247 | 0.010 |
Why?
|
Computational Biology | 2 | 2005 | 3518 | 0.010 |
Why?
|
X-Ray Diffraction | 1 | 2002 | 421 | 0.010 |
Why?
|
Lung | 1 | 2020 | 10000 | 0.010 |
Why?
|
Crystallography, X-Ray | 1 | 2005 | 1990 | 0.010 |
Why?
|
Introns | 1 | 2003 | 981 | 0.010 |
Why?
|
Databases as Topic | 1 | 2002 | 473 | 0.010 |
Why?
|
Pandemics | 1 | 2020 | 8654 | 0.010 |
Why?
|
Structure-Activity Relationship | 1 | 2005 | 3076 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2020 | 26198 | 0.010 |
Why?
|
Open Reading Frames | 1 | 2003 | 815 | 0.010 |
Why?
|
DNA, Complementary | 1 | 2003 | 1991 | 0.010 |
Why?
|
Risk Assessment | 1 | 2021 | 23995 | 0.010 |
Why?
|
Alternative Splicing | 1 | 2003 | 1093 | 0.010 |
Why?
|
Sequence Homology, Amino Acid | 1 | 2002 | 2748 | 0.010 |
Why?
|
Cloning, Molecular | 1 | 2003 | 4174 | 0.010 |
Why?
|
Exons | 1 | 2003 | 2391 | 0.010 |
Why?
|
Binding Sites | 1 | 2005 | 6055 | 0.010 |
Why?
|
Databases, Genetic | 1 | 2003 | 1742 | 0.010 |
Why?
|
Temperature | 1 | 2002 | 2226 | 0.010 |
Why?
|
Protein Structure, Tertiary | 1 | 2002 | 3792 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2016 | 17904 | 0.010 |
Why?
|
Risk Factors | 1 | 2021 | 74206 | 0.010 |
Why?
|
Evolution, Molecular | 1 | 2002 | 1886 | 0.010 |
Why?
|
Protein Binding | 1 | 2005 | 9351 | 0.010 |
Why?
|
Postoperative Complications | 1 | 2014 | 15631 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2002 | 13446 | 0.010 |
Why?
|
Hippocampus | 1 | 2002 | 3766 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2002 | 17635 | 0.010 |
Why?
|
Bacterial Proteins | 1 | 2002 | 3847 | 0.000 |
Why?
|
Epilepsy | 1 | 2002 | 3290 | 0.000 |
Why?
|